The protease-antiprotease battle in the cystic fibrosis lung

Khan T.Z. , Wagener J.S. , Bost T. , Martinez J. , Accurso F.J. , Riches D.W.H. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075–82.

Balough K. , McCubbins M. , Weinberger M. , Smits W. , Ahrens R. , Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995; 20: 63–70.

Konstan M.W. , Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997; 24: 137–42.

Copenhaver S. , Sage A. , Vasil A. BALF PCR and ELISA identification of non-culturable Pseudomonas aeruginosa in infants and toddlers with cystic fibrosis. Pediatr Pulmonol 1996; Suppl. 13: 291–2.

DiMango E. , Ratner A.J. , Bryan R. , Tabibi S. , Prince A. Activation of NF-KB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998; 101: 2598–605.

Bonfield T.L. , Konstan M.W. , Burfeind P. , Panuska J.R. , Hilliard J.B. , Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995; 13: 257–61.

Bonfield T.L. , Panuska J.R. , Konstan M.W. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111–18.

Armstrong D.S. , Grimwood K. , Carzino R. , Carlin J.B. , Olinsky A. , Phelan P.D. Lower respiratory tract infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995; 310: 1571–2.

Konstan M.W. , Hilliard K.A. , Norvell T.M. , Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448–54.

Richman-Eisenstat J.B.Y. , Jorens P.G. , Hébert C.A. , Ueki I. , Nadel J.A. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264(Lung Cell Mol Physiol 8): L413–18.

Dean T.P. , Dai Y. , Shute J.K. , Church M.K. , Warner J.O. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 1993; 34: 159–61.

Fick R.B. , Robbins R.A. , Squier S.U. , Schoderbek W.E. , Russ W.D. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res 1986; 20: 1258–68.

Konstan M.W. , Walenga R.W. , Hilliard K.A. , Hilliard J.B. Leukotriene B₄ markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 1993; 148: 896–901.

Birrer P. Consequences of unbalanced protease in the lung: protease involvement in destruction and local defence mechanisms of the lung. Agents Actions Supplement 1993; 40: 3–12.

Koller D.Y. , Urbanek R. , Götz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 1995; 152: 629–33.

Witko-Sarsat V. , Allen R.C. , Paulais M. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol 1996; 157: 2728–35.

Döring G. The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 1994; 150: S114–17.

Power C. , O'Connor C.M. , MacFarlane D. Neutrophil collagenase in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 1994; 150: 818–22.

Delacourt C. , Le Bourgeois M. , D'Orto M-P Imbalance between 95 kDa collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 1995; 152: 765–74.

O'Connor C.M. , Gaffney K. , Keane J. a_t-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis 1993; 148: 1665–70.

Meyer K.C. , Lewandoski J.R. , Zimmerman J.J. , Nunley D. , Calhoun W.J. , Dopico G.A. Human neutrophil elastase and elastase/alpha₁-antiproteases complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am Rev Respir Dis 1991; 144: 580–5.

Birrer P. , McElvaney N.G. , Rüdeberg A. Protease–antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994; 150: 207–13.

Vender R.L. , Burcham D.L. , Quon C.Y. DMP777: a synthetic human neutrophil-elastase inhibitor as therapy for cystic fibrosis. Pediatr Pulmonal 1998; 26(Suppl. 17): 136–7.

Stone P.J. , Konstan M.W. , Berger M. , Dorkin H.L. , Franzblau C. , Snider G.L. Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am J Respir Crit Care Med 1995; 152: 157–62.

Suter S. , Schaad U.B. , Morgenthaler J.J. , Chevallier I. , Schnebli H.P. Fibronectin-cleaving activity in bronchial secretions of patients with cystic fibrosis. J Infect Dis 1988; 138: 89–100.

Nadel J.A. Protease actions on airway secretions. Relevance to cystic fibrosis. Ann NY Acad Sci 1991; 624: 286–96.

Nakamura H. , Yoshimura K. , McElvaney N.G. , Crystal R.G. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992; 89: 1478–84.

Vogelmeier C. , Döring G. Neutrophil proteinases and rhDNase therapy in cystic fibrosis. Eur Respir J 1996; 9: 2193–5.

Costello C.M. , O'Connor C.M. , Finlay G.A. , Shiels P. , FitzGerald M.X. , Hayes J.P. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis. Thorax 1996; 51: 619–23.

Shah P.L. , Scott S.F. , Knight R.A. , Hodson M.E. The effects of recombinant DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis. Eur Respir J 1996; 9: 531–4.

Suter S. The role of bacterial proteases in the pathogenesis of cystic fibrosis. Am J Respir Crit Care Med 1994; 150: S118–22.

Döring G. The pathogenicity of elastase in CF lung disease. Pediatr Pulmonol 1998; 26(Suppl. 17): 133–4.

Döring G. , Hoiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun 1983; 42: 197–201.

Jagger K.S. , Banner D.R. , Warren R.L. Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. J Clin Microbiol 1983; 17: 55–9.

Storey D.G. , Ujack E.E. , Mitchell I. , Rabin H.R. Positive correlation of algD transcription to lash and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Inject Immun 1997; 65: 4061–7.

Sakata K. , Yajima H. , Tanaka K. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. Am Rev Respir Dis 1993; 148: 1061–5.

Elphick H.E. , Jones A. , Everard M.L. , Evans G.S. Antibiotic inhibition of proteases in cystic fibrosis. Eur Respir J 1998; 12(Suppl. 28): 271s.

Sponer M. , Nick H-P , Schnebli H-P. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa. Biol Chem Hoppe-Seyler 1991; 372: 963–70.

Vogelmeier C. , GiUissen A. , Buhl R. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity. Chest 1996; 110: 261S–6S.

Cantin A.M. , Lafrenaye S. , Bégin R.O. Antineutrophil elastase activity in cystic fibrosis serum. Pediatr Pulmonol 1991; 11: 249–53.

Cantin A. , Bilodeau G. , Bégin R. Granulocyte elastase-mediated proteolysis of α₁antitrypsin in cystic fibrosis bronchopulmonary secretions. Pediatr Pulmonol 1989; 7: 12–17.

Baumstark J.S. , Lee C.T. , Luby R.J. Rapid inactivation of α₁-protease inhibitor (α₁-antitrypsin) by elastase. Biochem Biophys Acta 1977; 482: 400–11.

Döring G. , Krogh-Johansen H. , Weidinger S. , Høiby N. Allotypes of α₁-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508. Pediatr Pulmonol 1994; 18: 3–7.

Mahadeva R. , Westerbeek R.C. , Perry D.J. α₁-Antitrypsin deficiency alleles and the Taq1 G→A allele in cystic fibrosis lung disease. Eur Respir J 1998; 11: 873–9.

De Water R. , Willems L.N.A. , Van Muijen G.N.P. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labelling technique using monoclonal antibodies. Am Rev Respir Dis 1986; 133: 882–90.

Bingle L. , Tetley T.D. Secretory leukoprotease inhibitor: partnering α₁-proteinase inhibitor to combat pulmonary inflammation. Thorax 1996; 51: 1273–4.

Vogelmeier C. , Hubbard R.C. , Fells G.A. Anti-neutrophil elastase defence of the normal human respiratory epithelial surface provided by secretory leukoprotease inhibitor. J Clin Invest 1991; 87: 482–8.

Gillissen A. , Birrer P. , McElvaney N.G. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol 1993; 75: 825–32.

Tomee J.F. , Koeter G.H. , Hiemstra P.S. , Kauffman H.F. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax 1998; 53: 114–16.

Abbinante-Nissen J.M. , Simpson L.G. , Leikauf G.D. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1995; 268(Lung Cell Mol Physiol 12): L601–6.

Allen E.D. Opportunities for the use of aerosolized α₁-antitrypsin for the treatment of cystic fibrosis. Chest 1996; 110: 256S–60S.

Wewers M.D. , Casolaro M.A. , Sellers S.E. Replacement therapy for alpha₁antitrypsin deficiency associated with emphysema. New Engl J Med 1987; 316: 1055–62.

McElvaney N. , Hubbard R. , Fells G. , Healy J. , Chernick M. , Crystal R.G. Intravenous α₁-antitrypsin therapy to reestablish anti-neutrophil elastase defenses of the pulmonary epithelial surface in cystic fibrosis. Am Rev Respir Dis 1990; 140: A83.

Vogelmeier C. , Kirlath I. , Warrington S. , Banik N. , Ulbrich E. , Du Bois R.M. The intrapulmonary half-life and safety of aerosolized α₁-protease inhibitor in normal volunteers. Am J Respir Crit Care Med 1997; 155: 536–41.

McElvaney N.G. , Hubbard R.C. , Birrer P. Aerosol α₁-antitrypsin treatment for cystic fibrosis. Lancet 1991; 337: 392–4.

Berger M, Konstan M, Hilliard J and the CF Prolastin Study Group. Aerosolized Prolastin (α₁protease inhibitor) in CF. Pediatr Pulmonol 1995; 20: 421.

Stolk J. , Camps J. , Feitsma H.I.J. , Hermans J. , Dijkman J.H. , Pauwels E.K.J. Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor. Thorax 1995; 50: 645–50.

McElvaney N.G. , Doujaiji B. , Moan M.J. , Burnham M.R. , Wu M.C. , Crystal R.G. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis 1993; 148: 1056–60.

McElvaney N.G. , Nakamura H. , Birrer P. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992; 90: 1296–1301.

Wright G. , Carver A. , Cottom D. High level expression of human alpha₁antritrypsin in the milk of transgenic sheep. Biotechnology 1991; 9: 830–4.

Carver A.S. , Dalrymple M.A. , Wright G. Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheep. Biotechnology 1993; 11: 1263–70.

Rees D.D. , Brain J.D. , Wohl M.E. , Humes J.L. , Mumford R.A. Inhibition of neutrophil elastase in CF sputum by L-658,758. J Pharmacol Exp Ther 1997; 283: 1201–6.

Schuster A. , Fahy J.V. , Ueki I. , Nadel J.A. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur Respir J 1995; 8: 10–14.

Jacobs F.A. , Mannes G.P. , Hiemstra P.S. , Schols A.M. , Buurman W.A. , Heijerman H.G. Effect of inhaled FK706 on inflammatory mediators of pulmonary disease in adult patients with CF. Pediatr Pulmonol 1998; 26(Suppl. 17): 375.

Canonico A.E. , Brigham K.L. , Carmichael L.C. Plasmid-liposome transfer of the α₁-antitrypsin gene to cystic fibrosis bronchial epithelial cells prevents elastase-induced cell detachment and cytokine release. Am J Respir Cell Mol Biol 1996; 14: 348–55.